Ausgabe 4/2021
Inhalt (13 Artikel)
Acknowledgement to Referees
Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
Adrian L. Rabinowicz, Enrique Carrazana, Edward T. Maggio
Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
Rosanne Sprute, Sofie Schumacher, Martina Pauls, Wolfgang Pauls, Oliver A. Cornely
Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
Charles E. Frost, Van Ly, Samira M. Garonzik
The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process
Aneal Khan, Sandra M. Sirrs, Daniel G. Bichet, Chantal F. Morel, Adina Tocoian, Lan Lan, Michael L. West
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
Pauline Vaflard, Xavier Paoletti, Vincent Servois, Patricia Tresca, Elvire Pons-Tostivint, Marie-Paule Sablin, Francesco Ricci, Delphine Loirat, Ségolène Hescot, Nouritza Torossian, Diana Bello Roufai, Maud Kamal, Edith Borcoman, Christophe Le Tourneau
Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus
Xuan Zhou, Tsung-I Lee, Min Zhu, Peiming Ma
Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study
Kimitaka Suetsugu, Shota Muraki, Junshiro Fukumoto, Ryosuke Matsukane, Yasuo Mori, Takeshi Hirota, Toshihiro Miyamoto, Nobuaki Egashira, Koichi Akashi, Ichiro Ieiri
Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
John Dodd, Robert Jordan, Marie Makhlina, Luana Pesco Koplowitz, Barry Koplowitz, Keith Barnett, Wei H. Yang, Carl Spana
The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study
Rushuang Chen, Zhenming Kang, Yaduan Wang, Jie Zhao, Shunyuan Li
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
Sneha V. Gupta, Marie C. Fanget, Christopher MacLauchlin, Valerie A. Clausen, Jing Li, Daniel Cloutier, Ling Shen, Gabriel J. Robbie, Erik Mogalian
Comment on: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
Karl-Uwe Petersen
Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
Igor V. Maev, Yury A. Kucheryavyy, Natalya B. Gubergrits, Ingo Bonnacker, Ekaterina A. Shelest, Gwendolyn P. Janssen‑van Solingen, J. Enrique Dominguez‑Munoz